SCHEMBL5456025

SCHEMBL5456025

COc1ccc(C)cc1NC(=O)Nc1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)c(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.53
KMT2A Q03164 7/20 0.51
ALDH1A1 P00352 4/20 0.51
LMNA P02545 2/20 0.51
TSHR P16473 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MAPT P10636 8/20 0.50
MEN1 O00255 6/20 0.50
CASP3 P42574 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
TP53 P04637 2/20 0.50
SENP6 Q9GZR1 1/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
HTR1A P08908 2/20 0.47
HTR1D P28221 2/20 0.47
HTR1B P28222 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
CA12 O43570 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460138 0.91 HTR1A (0.55) RAB9AKMT2AALDH1A1LMNAMAPT
SCHEMBL5458483 0.89 MEN1 (0.59) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5463492 0.89 RAB9A (0.56) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5462108 0.88 CASP3 (0.48) RAB9AKMT2AALDH1A1LMNANPSR1
SCHEMBL5455872 0.87 MAPT (0.56) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5456763 0.84 RAB9A (0.57) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5465547 0.84 MAPT (0.53) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5469390 0.83 WNT3A (0.53) RAB9AKMT2AALDH1A1LMNATSHR
SCHEMBL5459771 0.83 NPY2R (0.52) RAB9AKMT2ALMNANPSR1MAPT
SCHEMBL5421815 0.81 NPY2R (0.55) RAB9AKMT2AALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RAB9A 1528/4885KMT2A 1350/4885ALDH1A1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.